ANI PHARMACEUTICALS INC — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2018-06-06

Reporting Person: Walsh Patrick D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-06	Common Stock	A	1800	—	Acquired	1800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Stock Options	$65.86	A	2225	Acquired	2028-06-05	Common Stock (2225)	Direct

Footnotes

F1: The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020.